Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations.

Heckman PRA, Blokland A, Bollen EPP, Prickaerts J.

Neurosci Biobehav Rev. 2018 Apr;87:233-254. doi: 10.1016/j.neubiorev.2018.02.007. Epub 2018 Feb 15. Review.

2.

Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task.

Rychlik M, Bollen E, Rygula R.

Psychopharmacology (Berl). 2017 Feb;234(4):613-620. doi: 10.1007/s00213-016-4497-1. Epub 2016 Dec 8.

3.

Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.

Heckman PRA, van Duinen MA, Bollen EPP, Nishi A, Wennogle LP, Blokland A, Prickaerts J.

Int J Neuropsychopharmacol. 2016 Apr 2;19(10). pii: pyw030. doi: 10.1093/ijnp/pyw030.

4.

Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors.

Bollen E, Akkerman S, Puzzo D, Gulisano W, Palmeri A, D'Hooge R, Balschun D, Steinbusch HW, Blokland A, Prickaerts J.

Neuropharmacology. 2015 Aug;95:361-6. doi: 10.1016/j.neuropharm.2015.04.008. Epub 2015 Apr 17.

PMID:
25896769
5.

Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.

Bollen E, Puzzo D, Rutten K, Privitera L, De Vry J, Vanmierlo T, Kenis G, Palmeri A, D'Hooge R, Balschun D, Steinbusch HM, Blokland A, Prickaerts J.

Neuropsychopharmacology. 2014 Oct;39(11):2497-505. doi: 10.1038/npp.2014.106. Epub 2014 May 12.

6.

Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).

Zirkzee EJ, Huizinga TW, Bollen EL, van Buchem MA, Middelkoop HA, van der Wee NJ, le Cessie S, Steup-Beekman GM.

Lupus. 2014;23(1):31-8. doi: 10.1177/0961203313512540. Epub 2013 Nov 15.

PMID:
24243776
7.

Demyelinating disease in SLE: is it multiple sclerosis or lupus?

Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM.

Best Pract Res Clin Rheumatol. 2013 Jun;27(3):405-24. doi: 10.1016/j.berh.2013.07.010. Review.

PMID:
24238696
8.

7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice.

Bollen E, Vanmierlo T, Akkerman S, Wouters C, Steinbusch HM, Prickaerts J.

Behav Brain Res. 2013 Nov 15;257:8-12. doi: 10.1016/j.bbr.2013.09.029. Epub 2013 Sep 23.

PMID:
24070857
9.

Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.

Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, Bollen EL, van Buchem MA, Huizinga TW.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii76-9. doi: 10.1136/annrheumdis-2012-202369. Epub 2012 Dec 19.

PMID:
23253914
10.

Cerebral atrophy in elderly with subjective memory complaints.

Palm WM, Ferrarini L, van der Flier WM, Westendorp RG, Bollen EL, Middelkoop HA, Milles JR, van der Grond J, van Buchem MA.

J Magn Reson Imaging. 2013 Aug;38(2):358-64. doi: 10.1002/jmri.23977. Epub 2012 Dec 13.

PMID:
23239111
11.

Phosphodiesterases in neurodegenerative disorders.

Bollen E, Prickaerts J.

IUBMB Life. 2012 Dec;64(12):965-70. doi: 10.1002/iub.1104. Epub 2012 Nov 5. Review.

12.

Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy.

Zirkzee EJ, Steup-Beekman GM, van der Mast RC, Bollen EL, van der Wee NJ, Baptist E, Slee TM, Huisman MV, Middelkoop HA, Luyendijk J, van Buchem MA, Huizinga TW.

J Rheumatol. 2012 Nov;39(11):2118-26. doi: 10.3899/jrheum.120545. Epub 2012 Sep 15.

PMID:
22984275
13.

Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801.

Reneerkens OAH, Rutten K, Bollen E, Hage T, Blokland A, Steinbusch HWM, Prickaerts J.

Behav Brain Res. 2013 Jan 1;236(1):16-22. doi: 10.1016/j.bbr.2012.08.019. Epub 2012 Aug 19.

PMID:
22951181
14.

Object recognition testing: methodological considerations on exploration and discrimination measures.

Akkerman S, Blokland A, Reneerkens O, van Goethem NP, Bollen E, Gijselaers HJ, Lieben CK, Steinbusch HW, Prickaerts J.

Behav Brain Res. 2012 Jul 1;232(2):335-47. doi: 10.1016/j.bbr.2012.03.022. Epub 2012 Apr 3.

PMID:
22490364
15.

Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.

Hosseini-Sharifabad A, Ghahremani MH, Sabzevari O, Naghdi N, Abdollahi M, Beyer C, Bollen E, Prickaerts J, Roghani A, Sharifzadeh M.

Pharmacol Biochem Behav. 2012 May;101(3):311-9. doi: 10.1016/j.pbb.2012.01.017. Epub 2012 Jan 28.

PMID:
22306745
16.

Cerebral microbleeds and cognitive functioning in the PROSPER study.

van Es AC, van der Grond J, de Craen AJ, Westendorp RG, Bollen EL, Blauw GJ, Greenberg SM, van Buchem MA; PROSPER Study Group.

Neurology. 2011 Oct 11;77(15):1446-52. doi: 10.1212/WNL.0b013e318232ab1d. Epub 2011 Sep 28.

PMID:
21956727
17.

GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.

Bruno O, Fedele E, Prickaerts J, Parker LA, Canepa E, Brullo C, Cavallero A, Gardella E, Balbi A, Domenicotti C, Bollen E, Gijselaers HJ, Vanmierlo T, Erb K, Limebeer CL, Argellati F, Marinari UM, Pronzato MA, Ricciarelli R.

Br J Pharmacol. 2011 Dec;164(8):2054-63. doi: 10.1111/j.1476-5381.2011.01524.x.

18.

Electromyographic activity in the EEG in Alzheimer's disease: noise or signal?

van der Hiele K, Reijntjes RH, Vein AA, Westendorp RG, van Buchem MA, Bollen EL, Middelkoop HA, van Dijk JG.

Int J Alzheimers Dis. 2011 Mar 29;2011:547024. doi: 10.4061/2011/547024.

19.

Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging.

Luyendijk J, Steens SC, Ouwendijk WJ, Steup-Beekman GM, Bollen EL, van der Grond J, Huizinga TW, Emmer BJ, van Buchem MA.

Arthritis Rheum. 2011 Mar;63(3):722-32. doi: 10.1002/art.30157.

20.

Shape abnormalities of the striatum in Alzheimer's disease.

de Jong LW, Ferrarini L, van der Grond J, Milles JR, Reiber JH, Westendorp RG, Bollen EL, Middelkoop HA, van Buchem MA.

J Alzheimers Dis. 2011;23(1):49-59. doi: 10.3233/JAD-2010-101026.

PMID:
20930298
21.

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.

van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J.

Neurology. 2010 Sep 14;75(11):997-1002. doi: 10.1212/WNL.0b013e3181f25f06.

PMID:
20837967
22.

Early removal of the chest tube after complete video-assisted thoracoscopic lobectomies.

Göttgens KW, Siebenga J, Belgers EH, van Huijstee PJ, Bollen EC.

Eur J Cardiothorac Surg. 2011 Apr;39(4):575-8. doi: 10.1016/j.ejcts.2010.08.002. Epub 2010 Sep 15.

PMID:
20833554
23.

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.

Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT.

Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi: 10.1136/ard.2010.130476. Epub 2010 Aug 19.

PMID:
20724309
24.

The role of video-assisted thoracic surgery in the surgical treatment of superior sulcus tumors.

Truin W, Siebenga J, Belgers E, Bollen EC.

Interact Cardiovasc Thorac Surg. 2010 Oct;11(4):512-4. doi: 10.1510/icvts.2010.237941. Epub 2010 Jul 23.

PMID:
20656799
25.

A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study.

Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, Perry IJ, Breteler MM, Westendorp RG; PROSPER and Rotterdam Study.

Diabetes. 2010 Jul;59(7):1601-7. doi: 10.2337/db09-0568. Epub 2010 Apr 14.

26.

Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study.

Brouwer BG, Visseren FL, Algra A, van Bockel JH, Bollen EL, Doevendans PA, Greving JP, Kappelle LJ, Moll FL, Pijl H, Romijn JA, van der Wall EE, van der Graaf Y.

J Intern Med. 2010 Jul;268(1):83-93. doi: 10.1111/j.1365-2796.2010.02229.x. Epub 2010 Mar 3.

27.

Variation in the CBP gene involved in epigenetic control associates with cognitive function.

Trompet S, de Craen AJ, Jukema JW, Pons D, Slagboom PE, Kremer D, Bollen EL, Westendorp RG.

Neurobiol Aging. 2011 Mar;32(3):549.e1-8. doi: 10.1016/j.neurobiolaging.2009.12.019. Epub 2010 Jan 22.

PMID:
20096957
28.

TREX1 gene variant in neuropsychiatric systemic lupus erythematosus.

de Vries B, Steup-Beekman GM, Haan J, Bollen EL, Luyendijk J, Frants RR, Terwindt GM, van Buchem MA, Huizinga TW, van den Maagdenberg AM, Ferrari MD.

Ann Rheum Dis. 2010 Oct;69(10):1886-7. doi: 10.1136/ard.2009.114157. Epub 2009 Oct 28. No abstract available.

PMID:
19875384
29.

Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands.

Belgers EH, Siebenga J, Bosch AM, van Haren EH, Bollen EC.

Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):176-80. doi: 10.1510/icvts.2009.212878. Epub 2009 Oct 22.

PMID:
19850598
30.

Pravastatin and cognitive function in the elderly. Results of the PROSPER study.

Trompet S, van Vliet P, de Craen AJ, Jolles J, Buckley BM, Murphy MB, Ford I, Macfarlane PW, Sattar N, Packard CJ, Stott DJ, Shepherd J, Bollen EL, Blauw GJ, Jukema JW, Westendorp RG.

J Neurol. 2010 Jan;257(1):85-90. doi: 10.1007/s00415-009-5271-7. Epub 2009 Aug 4.

PMID:
19653027
31.

Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats.

Rutten K, Van Donkelaar EL, Ferrington L, Blokland A, Bollen E, Steinbusch HW, Kelly PA, Prickaerts JH.

Neuropsychopharmacology. 2009 Jul;34(8):1914-25. doi: 10.1038/npp.2009.24. Epub 2009 Mar 4.

32.

Supervised exercise therapy for intermittent claudication in daily practice.

Kruidenier LM, Nicolaï SP, Hendriks EJ, Bollen EC, Prins MH, Teijink JA.

J Vasc Surg. 2009 Feb;49(2):363-70. doi: 10.1016/j.jvs.2008.09.042. Epub 2008 Nov 22.

33.

Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study.

de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, de Bruin PW, Middelkoop HA, van Buchem MA, van der Grond J.

Brain. 2008 Dec;131(Pt 12):3277-85. doi: 10.1093/brain/awn278. Epub 2008 Nov 20.

34.

[Surgical treatment of lung cancer with complete VATS lobectomy, new in the Netherlands].

Bollen EC, Belgers E, van Haren EH, Siebenga J.

Ned Tijdschr Geneeskd. 2008 May 24;152(21):1204-9. Dutch.

PMID:
18578448
35.

Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.

Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Jukema JW; PROSPER Group.

Exp Gerontol. 2008 Aug;43(8):801-5. doi: 10.1016/j.exger.2008.04.006. Epub 2008 Apr 22.

PMID:
18504081
36.

EEG markers of future cognitive performance in the elderly.

van der Hiele K, Bollen EL, Vein AA, Reijntjes RH, Westendorp RG, van Buchem MA, Middelkoop HA, van Dijk JG.

J Clin Neurophysiol. 2008 Apr;25(2):83-9. doi: 10.1097/WNP.0b013e31816a5b25.

PMID:
18340274
37.

Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study.

Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Jukema JW, Westendorp RG; PROSPER Group.

Brain. 2008 Apr;131(Pt 4):1069-77. doi: 10.1093/brain/awn023. Epub 2008 Feb 26.

PMID:
18304957
38.

MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease.

Ferrarini L, Palm WM, Olofsen H, van der Landen R, Jan Blauw G, Westendorp RG, Bollen EL, Middelkoop HA, Reiber JH, van Buchem MA, Admiraal-Behloul F.

Neuroimage. 2008 Feb 15;39(4):1832-8. Epub 2007 Nov 17.

PMID:
18160312
39.

Association between apolipoprotein E4 and cognitive decline in elderly adults.

Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group.

J Am Geriatr Soc. 2007 Nov;55(11):1777-85.

PMID:
17979899
40.

Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging.

van Es AC, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen EL, Middelkoop HA, Weverling-Rijnsburger AW, van der Grond J, Westendorp RG, van Buchem MA.

AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1938-42. Epub 2007 Oct 9.

41.

EEG correlates in the spectrum of cognitive decline.

van der Hiele K, Vein AA, Reijntjes RH, Westendorp RG, Bollen EL, van Buchem MA, van Dijk JG, Middelkoop HA.

Clin Neurophysiol. 2007 Sep;118(9):1931-9. Epub 2007 Jun 28.

PMID:
17604688
42.

Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study.

Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Hyland M, Gaw A, Macfarlane PW, Packard CJ, Norrie J, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Jukema JW.

Ann N Y Acad Sci. 2007 Apr;1100:189-98.

PMID:
17460178
43.

Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities.

ten Dam VH, van den Heuvel DM, de Craen AJ, Bollen EL, Murray HM, Westendorp RG, Blauw GJ, van Buchem MA.

Radiology. 2007 Apr;243(1):198-203. Epub 2007 Feb 28.

PMID:
17329688
44.

C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).

Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J; PROSPER Study Group.

Circulation. 2007 Feb 27;115(8):981-9. Epub 2007 Feb 5.

PMID:
17283264
45.

Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke.

de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, Bollen EL, Bax JJ.

Stroke. 2006 Oct;37(10):2531-4. Epub 2006 Aug 31.

PMID:
16946152
46.

EEG and MRI correlates of mild cognitive impairment and Alzheimer's disease.

van der Hiele K, Vein AA, van der Welle A, van der Grond J, Westendorp RG, Bollen EL, van Buchem MA, van Dijk JG, Middelkoop HA.

Neurobiol Aging. 2007 Sep;28(9):1322-9. Epub 2006 Jul 18.

PMID:
16854500
47.

Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay.

Verheijen JH, Huisman LG, van Lent N, Neumann U, Paganetti P, Hack CE, Bouwman F, Lindeman J, Bollen EL, Hanemaaijer R.

Clin Chem. 2006 Jun;52(6):1168-74. Epub 2006 Apr 13.

48.

Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement.

van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, van Es AC, Palm WM, Spilt A, Bollen EL, Blauw GJ, Launer L, Westendorp RG, van Buchem MA; PROSPER Study Group.

AJNR Am J Neuroradiol. 2006 Apr;27(4):875-8.

49.

Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.

Versluis CE, van der Mast RC, van Buchem MA, Bollen EL, Blauw GJ, Eekhof JA, van der Wee NJ, de Craen AJ; PROSPER Study.

Int J Geriatr Psychiatry. 2006 Apr;21(4):375-81.

PMID:
16534770
50.

Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population.

van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL, Jolles J, Murray HM, Blauw GJ, Westendorp RG, van Buchem MA.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):149-53.

Supplemental Content

Loading ...
Support Center